Ascendis Pharma A/S
ASND · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$378 | -$481 | -$583 | -$384 |
| Dep. & Amort. | $18 | $19 | $18 | $15 |
| Deferred Tax | $5 | $0 | $5 | -$0 |
| Stock-Based Comp. | $96 | $67 | $64 | $67 |
| Change in WC | -$107 | -$96 | -$12 | -$48 |
| Other Non-Cash | $61 | $25 | $12 | -$68 |
| Operating Cash Flow | -$306 | -$467 | -$496 | -$418 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$14 | -$24 |
| Net Acquisitions | $0 | $0 | $0 | -$10 |
| Inv. Purchases | $0 | $0 | -$214 | -$226 |
| Inv. Sales/Matur. | $7 | $0 | $281 | $150 |
| Other Inv. Act. | $1 | $289 | $10 | -$1 |
| Investing Cash Flow | $7 | $286 | $62 | -$111 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $123 | $126 | $497 | -$6 |
| Stock Issued | $310 | $0 | $0 | $368 |
| Stock Repurch. | $0 | -$2 | -$105 | -$22 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11 | $10 | $5 | $12 |
| Financing Cash Flow | $444 | $134 | $397 | $351 |
| Forex Effect | $23 | -$6 | $36 | $39 |
| Net Chg. in Cash | $167 | -$53 | -$2 | -$138 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $392 | $445 | $446 | $585 |
| End Cash | $560 | $392 | $445 | $446 |
| Free Cash Flow | -$308 | -$470 | -$510 | -$442 |